Effect of synthetic human atrial natriuretic peptide (102-126) in nephrotic syndrome.
暂无分享,去创建一个
[1] F. Boomsma,et al. EFFECT OF UNNATURAL NORADRENALINE PRECURSOR ON SYMPATHETIC CONTROL AND ORTHOSTATIC HYPOTENSION IN DOPAMINE-BETA-HYDROXYLASE DEFICIENCY , 1987, The Lancet.
[2] R. Zimmerman,et al. Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog. , 1987, Circulation research.
[3] T. Tulassay,et al. Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome. , 1987, Kidney international.
[4] J. Biollaz,et al. Pharmacokinetics of synthetic atrial natriuretic peptides in normal men , 1987, Clinical pharmacology and therapeutics.
[5] N. Trippodo,et al. Atrial natriuretic factor decreases whole-body capillary absorption in rats. , 1987, The American journal of physiology.
[6] J. Fleming,et al. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney , 1986, Nature.
[7] M. Dunn,et al. A mechanism by which atrial natriuretic factor mediates its glomerular actions. , 1986, The American journal of physiology.
[8] Andrew,et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. , 1986, The Journal of clinical investigation.
[9] M. Cantin,et al. Distinct localization of atrial natriuretic factor and angiotensin II binding sites in the glomerulus. , 1986, The American journal of physiology.
[10] J. H. Stein,et al. Effect of atriopeptin II on determinants of glomerular filtration rate in the in vitro perfused dog glomerulus. , 1986, The American journal of physiology.
[11] J. O. Davis,et al. Renal Mechanisms for Suppression of Renin Secretion by Atrial Natriuretic Factor , 1986, Hypertension.
[12] P. Weidmann,et al. Blood levels and renal effects of atrial natriuretic peptide in normal man. , 1986, The Journal of clinical investigation.
[13] G. Brabant,et al. Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascites. , 1986, Klinische Wochenschrift.
[14] B. Brenner,et al. Biologically active atrial peptides. , 1985, The Journal of clinical investigation.
[15] E. Brown. The nephrotic syndrome. , 1985, Postgraduate medical journal.
[16] A. Richards,et al. Effects of alpha-human atrial natriuretic peptide in essential hypertension. , 1985, Hypertension.
[17] A. J. Man in't veld,et al. Splint renal function after captopril in unilateral renal artery stenosis. , 1984, British medical journal.
[18] P. Boer,et al. Plasma and blood volumes in patients with the nephrotic syndrome. , 1984, Nephron.
[19] B. G. Blijenberg,et al. The Introduction of Bromocresol Purple for the Determination of Serum Albumin on SMAC and ACA, and the Standardization Procedure , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.
[20] A. Ingild. Single Radial Immunodiffusion , 1983 .
[21] A. J. Man in 't Veld,et al. Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis. , 1983, Hypertension.
[22] A. D. de Bold,et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. , 1981, Life sciences.
[23] H. Rennke,et al. The Structural and Molecular Basis of Glomerular Filtration , 1978, Circulation research.
[24] C R Robertson,et al. Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions. , 1975, Kidney international.
[25] W. Flamenbaum,et al. Micropuncture studies of proximal tubule albumin concentrations in normal and nephrotic rats. , 1971, The Journal of clinical investigation.